CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
Broadcom/VMware: Navigating foreclosure theories across different jurisdictions
This case presented numerous conceptual challenges, notably the differing outcomes of the competitive assessments across 12 jurisdictions. While Broadcom was...